Company profile

4D Molecular Therapeutics, Inc. insider acquisitions

Company CIK 0001650648 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
FDMT · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Exercise / conversionCode MCommon StockNon-derivative · Currency not specified1Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 16, 20264D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Dec 20, 20254D Molecular Therapeutics, Inc.Common StockGupta AshooExercise / conversion
Dec 20, 20254D Molecular Therapeutics, Inc.Common StockGupta AshooExercise / conversion
Dec 16, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Dec 12, 20254D Molecular Therapeutics, Inc.Common StockTHEUER CHARLESExercise / conversion
Dec 9, 20254D Molecular Therapeutics, Inc.Stock Option (Right to Buy)Humer KristianStock award
Nov 17, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Oct 24, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion
Oct 16, 20254D Molecular Therapeutics, Inc.Common StockBizily ScottExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

FDMT · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade:
Gupta AshooVP, Finance and Controller
Exercise / conversionCommon StockNon-derivative security · Code M220Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Gupta AshooVP, Finance and Controller
Exercise / conversionCommon StockNon-derivative security · Code M866Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M9,3331.14Value: 10,639.62Currency not specifiedView ↗
Trade:
Humer KristianChief Financial Officer
Stock awardStock Option (Right to Buy)Derivative security · Code A480,0000Value: 0Currency not specifiedView ↗
Trade:
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗
Trade:
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,0846.49Value: 7,035.16Currency not specifiedView ↗
Trade:
Bizily ScottChief Legal Officer
Exercise / conversionCommon StockNon-derivative security · Code M1,6354.14Value: 6,768.9Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →